schistosomiasis japonicum vaccine

A schistosomiasis japonicum vaccine is a biological preparation designed to induce protective immunity against *Schistosoma japonicum*, the parasitic flatworm responsible for Asian schistosomiasis. These vaccines typically target various stages of the parasite's life cycle, such as the cercariae, schistosomula, or adult worms, using specific antigens like tegumental proteins (e.g., Sj23), enzymes (e.g., SjGST), or other larval proteins. The primary goal of such vaccines is to reduce the worm burden, decrease egg production (which causes the majority of clinical pathology), and interrupt the transmission cycle in endemic areas. While several candidates have reached preclinical or early clinical stages, no vaccine is currently widely approved for human use. Research by organizations like The 920 Hospital of the Chinese People's Liberation Army Joint Logistic Support Force has focused on public health aspects, including public acceptance and educational interventions to support future vaccine implementation in endemic regions.

Other names

Schistosoma japonicum vaccineAsian schistosomiasis vaccine